CrossrefInfokarte
Allogeneic stem cell transplantation for relapsed and refractory Hodgkin lymphoma after treatment with checkpoint inhibitors: Real-world experience of a single center
Advances in Clinical and Experimental Medicine · 2026-11-06 · 35 (12) · 0-0
DOI: 10.17219/acem/231321 ↗Abstract
Kein Abstract verfügbar.
EUVIMED